0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Minocycline Treatment of Rheumatoid Arthritis

Harold E. Paulus, MD
[+] Article and Author Information

University of California, Los Angeles, School of Medicine; Los Angeles, CA 90024-1670 Requests for Reprints: Harold E. Paulus, MD, University of California, Los Angeles, School of Medicine, 1000 Veteran Avenue, 32-41, Los Angeles, CA 90024-1670.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;122(2):147-148. doi:10.7326/0003-4819-122-2-199501150-00012
Text Size: A A A

Two recent reports have created renewed interest in antibiotic treatment of rheumatoid arthritis: In this issue, Tilley and colleagues [1] report the findings of the large double-blind, placebo-controlled Minocycline in Rheumatoid Arthritis (MIRA) clinical trial; in 1994, Kloppenburg and colleagues [2] reported the results of a similar study from the Netherlands. In 1968, Sanchez [3] first reported the use of tetracycline to treat 14 patients with rheumatoid arthritis, with favorable results. McPherson-Brown and colleagues [4] also found good results in a retrospective cohort study of 98 patients with rheumatoid arthritis who were treated with antibiotics from 1978 to 1982. However, these reports were largely discounted because a 1971 double-blind study of 30 patients with rheumatoid arthritis who were randomly assigned to receive either placebo or 250 mg of tetracycline daily for 1 year failed to show any significant benefit in those receiving tetracycline therapy [5]. In two other recent open trials, patients receiving daily oral minocycline treatment showed clinical improvement [67].

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)